PPARGC1A and type 2 diabetes mellitus: Third, the PPARγ2 Pro12Ala and the PGC1α Gly482Ser polymorphisms were associated with conversion fromimpaired glucose tolerance to T2DM in the STOP-NIDDM trial [38].